SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001013762-24-002069
Filing Date
2024-07-29
Accepted
2024-07-29 16:01:18
Documents
13
Period of Report
2024-07-23
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0210184-8k_bimi.htm   iXBRL 8-K 28216
  Complete submission text file 0001013762-24-002069.txt   201823

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE bimi-20240723.xsd EX-101.SCH 3009
3 XBRL LABEL FILE bimi-20240723_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE bimi-20240723_pre.xml EX-101.PRE 22355
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0210184-8k_bimi_htm.xml XML 3672
Mailing Address 725 5TH AVENUE, 15TH FLOOR, 15-01 NEW YORK NY NEW YORK
Business Address 725 5TH AVENUE, 15TH FLOOR, 15-01 NEW YORK NY NEW YORK 212-542-0028
BIMI Holdings Inc. (Filer) CIK: 0001213660 (see all company filings)

IRS No.: 020563302 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34890 | Film No.: 241152241
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries
(CF Office: 07 Trade & Services)